Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

Clinical trial NCT00516464 · UNKNOWN

Trial details

NCT number: NCT00516464
Sponsor: Retina Associates, Kansas City
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Proliferative Diabetic Retinopathy

Start date: 2007-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.